Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2015 Mar 5;35(5):1156–1165. doi: 10.1161/ATVBAHA.114.304776

Fig 2. AngII increases hepatic and abdominal aorta SAA mRNA abundance and plasma SAA concentrations in mice.

Fig 2

A) SAA mRNA abundance in livers of male apoE−/− mice 24 hours after i.p. injection of saline or 100 μg/kg AngII (n = 4). B) Plasma SAA concentrations in male apoE−/− mice 24 hours after i.p. injection of saline or 100 μg/kg AngII (n = 4). C) SAA mRNA abundance in livers of male apoE−/− mice after 28-day infusion of saline (n = 5) or 1,000 ng kg−1 min−1 AngII (n = 9). D) Plasma SAA concentrations in male apoE−/− mice after 28-day infusion of saline (n = 5) or 1,000 ng kg−1 min−1 AngII (n = 9). E) SAA mRNA abundance in abdominal aortas of male apoE−/− mice after 10-day infusion of saline (n = 4) or 1,000 ng kg−1 min−1 AngII (n = 7). F) SAA mRNA abundance in thoracic aortas of male apoE−/− mice after 10-day infusion of saline (n = 4) or 1,000 ng kg−1 min−1 AngII (n = 6). Values represent the mean ± SEM; *P<0.05, **P<0.01, ***P<0.001 for saline vs AngII.